https://www.prnewswire.com/news-releases/cvs-caremark-issues-statement-on-settlement-concerning-retail-pharmacy-reimbursements-for-certain-medicaid-patients-119934919.html
/PRNewswire/ -- CVS Caremark announced today that it has reached a settlement agreement with the U.S. Department of Justice, the Office of Inspector General...
cvs caremarkissues statementretail pharmacysettlementconcerning
https://www.stlouis-mo.gov/government/departments/public-safety/emergency-management/news/emergency-prescription-waiver-notice.cfm
Bulletin issued by the Missouri Department of Commerce and Insurance at 05/22/2025 09:19 AM CDT
pharmacy issuesmissouriboardemergencyprescription
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/amex-pharmacy-issues-voluntary-nationwide-recall-one-lot-bevacizumab-125mg005ml-31-g-syringe-due
AmEx Pharmacy is voluntarily recalling one Lot of Bevacizumab 1.25mg/0.05mL 31G Injectable to the consumer/user level. The Monoject Syringe of this product may...
pharmacy issuesamexvoluntarynationwiderecall
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/premier-pharmacy-labs-issues-voluntary-nationwide-recall-all-unexpired-sterile-drug-product-lots-due
Premier Pharmacy Labs is voluntarily recalling all unexpired products, intended to be sterile, due to a lack of sterility assurance.
premierpharmacylabsissuesvoluntary
https://www.pharmacytimes.com/view/fda-issues-crl-to-vatiquinone-nda-indicated-for-friedreich-ataxia
The complete response letter (CRL) stated that vatiquinone's new drug application (NDA) did not provide substantial evidence of efficacy and would need to be...
friedreich ataxiafdaissuescrlnda
https://www.pharmacytimes.com/view/adherence-issues-with-antidepressants-in-bipolar-patients
Bipolar patients are among the most difficult to treat, in part because mania is alluring and in part because they are often poor historians. As with any...
adherenceissuesantidepressantsbipolarpatients